Instinct Bio completes merger with Relativity Acquisition, Nasdaq trading to start July 24

RELATIVITY ACQUISITION CORP

RELATIVITY ACQUISITION CORP

ACQC

0.00
  • Instinct Bio completed its business combination with Relativity Acquisition Corp., positioning the regenerative medicine and longevity group to list on Nasdaq.
  • Instinct Bio common stock and warrants are expected to start trading July 24, 2026 under the tickers BIOT and BIOTW.
  • The deal implies a pro forma enterprise value of about $288 million at closing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relativity Acquisition Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607231615PRIMZONEFULLFEED9767271) on July 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.